Psychemedics Corp financial data

Symbol
PMDI on OTC
Industry
Services-Medical Laboratories
Location
125 Nagog Park, Acton, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 24, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 161 % +6.54%
Debt-to-equity 74.4 % -9.05%
Return On Equity -32.9 % +33.8%
Return On Assets -18.9 % +31%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.11M shares +5.23%
Common Stock, Shares, Outstanding 6.11M shares +5.24%
Entity Public Float 14.2M USD -35.7%
Common Stock, Value, Issued 33K USD +3.13%
Weighted Average Number of Shares Outstanding, Basic 5.87M shares +2.21%
Weighted Average Number of Shares Outstanding, Diluted 5.74M shares +2.03%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 749K USD -34.5%
Selling and Marketing Expense 2.55M USD -14.9%
General and Administrative Expense 5.7M USD -20.8%
Operating Income (Loss) -1.89M USD +35.2%
Nonoperating Income (Expense) -23K USD +95.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.92M USD +44.3%
Income Tax Expense (Benefit) -55K USD -108%
Net Income (Loss) Attributable to Parent -1.86M USD +55.2%
Earnings Per Share, Basic -0.32 USD/shares +55.6%
Earnings Per Share, Diluted -0.68 USD/shares -94.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.42M USD -27.9%
Accounts Receivable, after Allowance for Credit Loss, Current 2.5M USD -32.2%
Assets, Current 4.94M USD -27.4%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 2M USD -34.6%
Operating Lease, Right-of-Use Asset 844K USD -53.8%
Other Assets, Noncurrent 455K USD -28%
Assets 8.32M USD -32.5%
Accounts Payable, Current 462K USD -38.6%
Accrued Liabilities, Current 1.56M USD -40.1%
Liabilities, Current 2.71M USD -42.4%
Deferred Income Tax Liabilities, Net 7K USD
Operating Lease, Liability, Noncurrent 424K USD -55.1%
Liabilities 3.19M USD -43.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.63M USD 0%
Retained Earnings (Accumulated Deficit) -18.6M USD -11.1%
Stockholders' Equity Attributable to Parent 5.13M USD -23.1%
Liabilities and Equity 8.32M USD -32.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -473K USD -110%
Net Cash Provided by (Used in) Financing Activities -75K USD -4.17%
Net Cash Provided by (Used in) Investing Activities 5K USD
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 6.78M shares +4.7%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -543K USD -46.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4K USD -20%
Deferred Tax Assets, Valuation Allowance 2.66M USD +3.14%
Deferred Tax Assets, Gross 3.17M USD -10.1%
Operating Lease, Liability 876K USD -56%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 957K USD -53.9%
Property, Plant and Equipment, Gross 24.2M USD -9.47%
Operating Lease, Liability, Current 452K USD -56.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 553K USD -47.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.06M USD -6.44%
Operating Lease, Weighted Average Discount Rate, Percent 3.8 pure -2.56%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 81K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 460K USD -16.8%
Deferred Tax Assets, Operating Loss Carryforwards 545K USD +526%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 873K shares 0%
Operating Lease, Payments 287K USD -1.38%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 508K USD -46.2%
Share-based Payment Arrangement, Expense 917K USD +0.99%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%